Bilcare FY26 net profit at ₹0.99 crore, loss narrows
Bilcare Limited's FY26 standalone net profit fell to ₹0.99 crore from ₹3.99 crore, with revenue dropping to ₹6.85 crore. The consolidated net loss narrowed to ₹17.29 crore. The company redeemed ₹15.60 crore preference shares in Caprihans India Limited and converted warrants, increasing its stake to 62.04%. The auditors flagged a material uncertainty regarding the company's status as a going concern.
*this image is generated using AI for illustrative purposes only.
Bilcare Limited reported a standalone net profit of ₹0.99 crore for the financial year ended March 31, 2026, a decrease from ₹3.99 crore in the previous year. Revenue from operations for the year stood at ₹6.85 crore, compared to ₹15.12 crore in the prior year. The Board of Directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, at a meeting held on May 29, 2026.
The company redeemed 1,56,00,000 preference shares of Caprihans India Limited at ₹10 each, aggregating to ₹15.60 crore. The redemption occurred in two tranches on May 28 and May 29, 2026. Additionally, Bilcare exercised its right to convert 10,40,000 warrants into equity shares of Caprihans India Limited at a price of ₹200 each. Following the allotment, the company's shareholding in Caprihans India Limited increased to 62.04%.
Financial Performance
The standalone financial results showed a total income of ₹26.38 crore for FY26, lower than ₹32.97 crore in the previous year. Total expenses decreased to ₹22.66 crore from ₹27.52 crore in the prior year. For the quarter ended March 31, 2026, the company reported a net loss of ₹6.35 crore, compared to a net profit of ₹3.36 crore in the same quarter of the previous year.
| Particulars | Year ended 31 March 2026 (₹ in Crores) | Year ended 31 March 2025 (₹ in Crores) |
|---|---|---|
| Revenue from operations | 6.85 | 15.12 |
| Total income | 26.38 | 32.97 |
| Total expenses | 22.66 | 27.52 |
| Net profit / (loss) for the period | 0.99 | 3.99 |
Consolidated Results
On a consolidated basis, the company reported a net loss of ₹17.29 crore for FY26, compared to a net loss of ₹28.13 crore in the previous year. Revenue from operations for the group stood at ₹733.54 crore, down from ₹788.04 crore in the prior year. The consolidated results include the financials of subsidiaries such as Caprihans India Limited and Bilcare Research GmbH.
The statutory auditors, M/s. Patki & Soman, Chartered Accountants, issued an unmodified opinion on the standalone and consolidated financial results. The auditors noted a material uncertainty related to the company's ability to continue as a going concern, dependent on the execution of strategic plans and future business prospects for the GCS business. The Board of Directors did not recommend any dividend for the year ended March 31, 2026.
Historical Stock Returns for Bilcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.58% | +2.67% | +2.95% | +0.69% | +0.69% | +0.69% |
What specific strategic plans does Bilcare intend to execute to address the auditors' concerns regarding its going concern status?
How will the increased 62.04% stake in Caprihans India Limited influence Bilcare's future revenue streams and operational focus?
What measures is the management taking to reverse the decline in standalone revenue from operations seen in FY26?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
